iHealth Pharma Limited operates as an agile investment firm focused on identifying and fostering high-impact ventures across medical diagnostics, biotechnology, and therapeutics.
By deploying targeted growth capital and strategic oversight, we mitigate early-stage commercialisation risks to accelerate the transition of transformative medical science into global healthcare markets.